Akuter Myokardinfarkt: Fibrinolyse versus PTCA

• LITERATUR

• 1 Chazov EI, Matveeva LS, Masaev AV. In-tracoronary administration of fibrinolysin in acute myocardial infarct. Ter Arkh 1976; 48: 8-19.
• 2 Rentrop P, Blanke H, Karsch KR. et al. Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase in combination with transluminal recanalization. Clin Cardiol 1979; 2: 354-63.
• 3 Gruppo Italiano per lo Studio della Strepto-chinasi nell’Infarto miocardico (GISSI).. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; I: 397-402.
• 4 The TIMI Research Group.. Immediate versus delayed catherization and angioplasty following thrombolytic therapy for acute myocardial infarction: the TIMI II a results. JAMA 1988; 18: 2849-58.
• 5 The TIMI Study Group.. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1989; 320: 618-27.
• 6 The GUSTO Angiographic Investigators.. The effects of tissue plasminogen activator, streptokinase, or both on coronary patency, ventricular fundtion and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615-22.
• 7 The Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronay Arteries (GUSTO) Investigators.. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-82.
• 8 Anderson JL, Karagounis LA, Becker LC. et al. TIMI perfusion grade III but not grade II results in improved outcome after thrombolysis for myocardial infarction. Circulation 1993; 87: 1829-39.
• 9 Welty FK, Mittelmar MA, Lewis SM. et al. A patent infarct-related artery is associated with reduced long-term mortality after percutaneous transluminal coronary angioplasty for postinfarction ischemia and an ejection fraction <50%. Circulation 1996; 93: 1496-1501.
• 10 Meyer J, Merx W, Dörr R. et al. Successful treatment of acute myocardial infarction shock by combined percutaneous transluminal coronary revascularization (PTCR) and percutaneous transluminal coronary angioplasty (PTCA). Am Heart J 1982; 103: 132-4.
• 11 Hartzler GO, Rutherford BD, McConahay DR. et al. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J 1983; 106: 965-73.
• 12 Erbel R, Pop T, Henrichs KJ. et al. Percutaneous transluminal coronary angioplasty after thrombolytic therapy: a prospective controlled randomized trial. J Am Coll Cardiol 1986; 8: 485-95.
• 13 Verheugt FWA, Meijer A, Lagrand WK, van Eenige MJ. Reocclusion: the flip side of coronary thrombolysis. J Am Coll Cardiol 1996; 27: 766-73.
• 14 Meyer J, Merx W, Dörr R. et al. Successful treatment of acute myocardial infarction shock by combined percutaneous transluminal coronary revascularisation (PTCR) and percutaneous transluminal coronary angioplasty (PTCA). Am Heart J 1982; 103: 132-4.
• 15 Schlant RC, O’Rourke RA, Collen D. et al. Reperfusion in acute myocardial infarction. Circulation 1994; 90: 2091-2102.
• 16 The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.. Acute myocardial infarction: pre-hospital and in-hospital management. Eur Heart J 1996; 17: 43-63.
• 17 Grines CL, Browne KR. Marco et al. A comparison of primary angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 328: 673-9.
• 18 Zijlstra F, DeBoer MJ, Hoorntje JCA. et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680-4.
• 19 Gibbons RJ, Holmes DR, Reeder GS. et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993; 328: 685-91.
• 20 Zijlstra F. Br Heart J 1995; 73: 403-4.
• 21 de Boer MJ, Suryapranata H, Hoorntje CA. et al. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intrevenous streptokinase in acute myocardial infarction. Circulation 1994; 90: 753-61.
• 22 Zijlstra F, de Boer MJ, Ottervange JP. et al. Direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: differences in clinical outcome during a mean follow-up of 18 months. Eur Heart J 1993; 14 suppl 279.
• 23 De Boer MJ, van Hout BA, Liem AL. et al. A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction. Am J Cardiol 1995; 76: 830-3.
• 24 Erbel R, Pop T, Diefenbach Ch, Meyer J. Long-term results of thrombolytic therapy with and without percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1989; 14: 276-85.
• 25 Lee L, Erbel R, Brown TM. et al. Multicenter registry of angioplasty therapy of cardiogenic shock: initial and long-term survival. J Am Coll Cardiol 1991; 17: 599-603.
• 26 Moosvi AR, Khaja F, Villanueva L. et al. Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 1992; 19: 907-14.
• 27 Bengtson JR, Kaplan AJ, Pieper KS. et al. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol 1992; 20: 1482-9.
• 28 Bauters C, Khanogan P, McFadden EP. et al. Restenosis after delayed coronary angioplasty of the culprit vessel in patients with a recent myocardial infarction treated by thrombolysis. Circulation 1995; 91: 1410-8.
• 29 Gorge G, Haude M, Ge J. et al. Intravascular ultrasound after low and high inflation pressure coronary artery stent implantation. J Am Coll Cardiol 1995; 26: 725-30.
• 30 Saito S, Hosokawa G. Kim et al. Primary stent implantation with Verheugt FWA, Meijer A, Lagrand WK, van Eenige MJ. Reocclusion: the flip side of coronary thrombolysis. J Am Coll Cardiol 1996; 27: 766-73.
• 31 Monassier JP. Coronary Stents in Acute Myocardial Infarction: Results of the French Registry. Sixth Complex Coronary Angioplasty Course. Toulouse, France: 1995.
• 32 Colombo A, Hall P, Nakamura S. et al. Intra-coronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995; 91: 1676-88.
• 33 The EPIC Investigators.. Use of monoclonal antibody directed against the platelet glycoprotein Ilb/IIIa receptor in hish-risk coronary angioplasty. N Engl J Med 1994; 330: 956-61.
• 34 Rupprecht HJ, Terres W, Özbek C. et al. Recombinant hirudin (HBW 023) prevents troponin T release after coronary angioplasty in patients with unstable angina. J Am Coll Cardiol 1995; 26: 1637-42.
• 35 Darius H, Beisiegel B, Erbel R. et al. Stimulation of platelet activity in diagnostic and therapeutic interventions in cardiology. Z Kardiol 1991; 80: 65-70.